Codexis (CDXS) Times Interest Earned (2010 - 2026)
Codexis' (CDXS) quarterly Times Interest Earned came in at -$0.2 in Q1 2026, up 98.83% year-on-year from -$0.1 in Q1 2025, and down 101.71% quarter-over-quarter from $11.64 in Q4 2025.
Codexis (CDXS) Times Interest Earned (2010 - 2026) Analysis & Trends
Codexis' Times Interest Earned history runs 17 years deep, the most recent figure standing at -$0.2 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 98.83% year-over-year to -$0.2 in Q1 2026; TTM through Mar 2026 was -$0.72, a 95.26% increase from a year earlier, with the FY2025 full-year figure at -$8.57, down 1995.14% from the prior year.
- Times Interest Earned slipped to -$0.2 in Q1 2026 per CDXS's latest filing, from $11.64 in the prior quarter.
- Across five years, Times Interest Earned topped out at $11.64 in Q4 2025 and bottomed at -$1063.6 in Q3 2022.
- The 5-year median for Times Interest Earned is -$5.66 (2023), against an average of -$67.91.
- Across the five-year window, Times Interest Earned tumbled 2250933.5% in 2022 and jumped 287.92% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$2.04 in 2022, then soared by 97.55% to -$0.05 in 2023, then tumbled by 12298.69% to -$6.19 in 2024, then soared by 287.92% to $11.64 in 2025, then sank by 101.71% to -$0.2 in 2026.
- Per Business Quant, the three latest CDXS Times Interest Earned figures stand at -$0.2 (Q1 2026), $11.64 (Q4 2025), and -$0.52 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | -0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.20 |
| Dec 31, 2025 | 11.64 |
| Sep 30, 2025 | -0.52 |
| Jun 30, 2025 | -0.34 |
| Mar 31, 2025 | -16.96 |
| Dec 31, 2024 | -6.19 |
| Sep 30, 2024 | -16.56 |
| Jun 30, 2024 | -22.73 |
| Mar 31, 2024 | -10.13 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | -5.66 |
| Jun 30, 2023 | -0.26 |
| Mar 31, 2023 | -12.57 |
| Dec 31, 2022 | -2.04 |
| Sep 30, 2022 | -1,063.60 |
| Jun 30, 2022 | -0.05 |
| Mar 31, 2022 | -8.21 |
| Dec 31, 2021 | -9.87 |
| Sep 30, 2021 | 0.05 |
| Jun 30, 2021 | -0.15 |